These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 27609943)

  • 1. Discovery of new biomarkers for atrial fibrillation using a custom-made proteomics chip.
    Lind L; Sundström J; Stenemo M; Hagström E; Ärnlöv J
    Heart; 2017 Mar; 103(5):377-382. PubMed ID: 27609943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NT-proBNP is a powerful predictor for incident atrial fibrillation - Validation of a multimarker approach.
    Svennberg E; Lindahl B; Berglund L; Eggers KM; Venge P; Zethelius B; Rosenqvist M; Lind L; Hijazi Z
    Int J Cardiol; 2016 Nov; 223():74-81. PubMed ID: 27541645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploration of pathophysiological pathways for incident atrial fibrillation using a multiplex proteomic chip.
    Molvin J; Jujic A; Melander O; Pareek M; Råstam L; Lindblad U; Daka B; Leosdottir M; Nilsson P; Olsen M; Magnusson M
    Open Heart; 2020; 7(1):e001190. PubMed ID: 32201587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating proteins as predictors of incident heart failure in the elderly.
    Stenemo M; Nowak C; Byberg L; Sundström J; Giedraitis V; Lind L; Ingelsson E; Fall T; Ärnlöv J
    Eur J Heart Fail; 2018 Jan; 20(1):55-62. PubMed ID: 28967680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of New Risk Markers for Ischemic Stroke Using a Novel Targeted Proteomics Chip.
    Lind L; Siegbahn A; Lindahl B; Stenemo M; Sundström J; Ärnlöv J
    Stroke; 2015 Dec; 46(12):3340-7. PubMed ID: 26542692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of a proximity extension assay proteomics chip to discover new biomarkers for human atherosclerosis.
    Lind L; Ärnlöv J; Lindahl B; Siegbahn A; Sundström J; Ingelsson E
    Atherosclerosis; 2015 Sep; 242(1):205-10. PubMed ID: 26204497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomics Profiling and Risk of New-Onset Atrial Fibrillation: Framingham Heart Study.
    Ko D; Benson MD; Ngo D; Yang Q; Larson MG; Wang TJ; Trinquart L; McManus DD; Lubitz SA; Ellinor PT; Vasan RS; Gerszten RE; Benjamin EJ; Lin H
    J Am Heart Assoc; 2019 Mar; 8(6):e010976. PubMed ID: 30841775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Proteomics To Investigate Kidney Function Decline over 5 Years.
    Carlsson AC; Ingelsson E; Sundström J; Jesus Carrero J; Gustafsson S; Feldreich T; Stenemo M; Larsson A; Lind L; Ärnlöv J
    Clin J Am Soc Nephrol; 2017 Aug; 12(8):1226-1235. PubMed ID: 28784837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-type natriuretic peptide for incident atrial fibrillation-The Heinz Nixdorf Recall Study.
    Kara K; Geisel MH; Möhlenkamp S; Lehmann N; Kälsch H; Bauer M; Neumann T; Dragano N; Moebus S; Jöckel KH; Erbel R; Mahabadi AA
    J Cardiol; 2015 Jun; 65(6):453-8. PubMed ID: 25241013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma Proteomic Insights for Identification of Novel Predictors and Potential Drug Targets in Atrial Fibrillation: A Prospective Cohort Study and Mendelian Randomization Analysis.
    Peng X; Li Y; Liu N; Xia S; Li X; Lai Y; He L; Sang C; Dong J; Ma C
    Circ Arrhythm Electrophysiol; 2024 Oct; 17(10):e013037. PubMed ID: 39355913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomics and Risk of Atrial Fibrillation in Older Adults (From the Atherosclerosis Risk in Communities [ARIC] Study).
    Norby FL; Tang W; Pankow JS; Lutsey PL; Alonso A; Steffen BT; Chen LY; Zhang M; Shippee ND; Ballantyne CM; Boerwinkle E; Coresh J; Folsom AR
    Am J Cardiol; 2021 Dec; 161():42-50. PubMed ID: 34794617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between Baseline Natriuretic Peptides and Atrial Fibrillation Recurrence After Catheter Ablation.
    Zhang Y; Chen A; Song L; Li M; Chen Y; He B
    Int Heart J; 2016; 57(2):183-9. PubMed ID: 26973277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma Protein Profile of Incident Myocardial Infarction, Ischemic Stroke, and Heart Failure in 2 Cohorts.
    Lind L; Ärnlöv J; Sundström J
    J Am Heart Assoc; 2021 Jun; 10(12):e017900. PubMed ID: 34096334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community.
    Schnabel RB; Larson MG; Yamamoto JF; Sullivan LM; Pencina MJ; Meigs JB; Tofler GH; Selhub J; Jacques PF; Wolf PA; Magnani JW; Ellinor PT; Wang TJ; Levy D; Vasan RS; Benjamin EJ
    Circulation; 2010 Jan; 121(2):200-7. PubMed ID: 20048208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased perioperative N-terminal pro-B-type natriuretic peptide levels predict atrial fibrillation after thoracic surgery for lung cancer.
    Cardinale D; Colombo A; Sandri MT; Lamantia G; Colombo N; Civelli M; Salvatici M; Veronesi G; Veglia F; Fiorentini C; Spaggiari L; Cipolla CM
    Circulation; 2007 Mar; 115(11):1339-44. PubMed ID: 17339553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of atrial fibrillation on plasma von willebrand factor, soluble E-selectin, and N-terminal pro B-type natriuretic peptide levels in systolic heart failure.
    Freestone B; Gustafsson F; Chong AY; Corell P; Kistorp C; Hildebrandt P; Lip GY
    Chest; 2008 May; 133(5):1203-8. PubMed ID: 18339785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of plasma NT-pro-BNP levels in patients with atrial fibrillation and preserved left ventricular ejection fraction.
    Letsas KP; Filippatos GS; Pappas LK; Mihas CC; Markou V; Alexanian IP; Efremidis M; Sideris A; Maisel AS; Kardaras F
    Clin Res Cardiol; 2009 Feb; 98(2):101-6. PubMed ID: 18975023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced prediction of atrial fibrillation risk using proteomic markers: a comparative analysis with clinical and polygenic risk scores.
    Liu M; Zhang Y; Ye Z; He P; Zhou C; Yang S; Zhang Y; Gan X; Qin X
    Heart; 2024 Oct; 110(21):1270-1276. PubMed ID: 39237126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of N-terminal pro-brain natriuretic peptide as a predictor of atrial fibrillation after cardiac surgery.
    Kallel S; Jarrya A; Triki Z; Abdenadher M; Frikha J; Karoui A
    J Cardiovasc Surg (Torino); 2013 Jun; 54(3):403-11. PubMed ID: 23172377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of N-terminal pro-B-type natriuretic Peptide levels for stroke risk prediction in anticoagulated patients with atrial fibrillation.
    Roldán V; Vílchez JA; Manzano-Fernández S; Jover E; Gálvez J; Puche CM; Valdés M; Vicente V; Lip GY; Marín F
    Stroke; 2014 Mar; 45(3):696-701. PubMed ID: 24519407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.